Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2012; 18(22): 2844-2849
Published online Jun 14, 2012. doi: 10.3748/wjg.v18.i22.2844
Published online Jun 14, 2012. doi: 10.3748/wjg.v18.i22.2844
Clinical parameter | n | XAF1 methylation status | P value | |
Methylatedn = 30 (75%) | Unmethylatedn = 10 (25%) | (χ2test) | ||
Age (yr) | ||||
< 65 | 40 | 30 (75) | 10 (25) | 1.0 |
≥ 65 | 32 | 24 (75) | 8 (25) | |
Gender | ||||
Male | 53 | 40 (75.5) | 13 (24.5) | 0.8773 |
Female | 19 | 14 (73.7) | 5 (26.3) | |
Tumor size (cm) | ||||
< 5 | 48 | 33 (68.8) | 15 (31.2) | |
≥ 5 | 24 | 21 (87.5) | 3 (12.5) | 0.0833 |
Tumor stage | ||||
I | 12 | 6 (50.0) | 6 (50.0) | 0.081 |
II | 21 | 17 (81.0) | 4 (19.0) | |
III | 6 | 6 (100.0) | 0 (0) | |
IV | 1 | 1 (100) | 0 (0) | |
Metastasis | ||||
Negative | 45 | 33 (73.3) | 12 (26.7) | 0.6733 |
Positive | 27 | 21 (77.8) | 6 (22.2) |
- Citation: Chen XY, He QY, Guo MZ. XAF1 is frequently methylated in human esophageal cancer. World J Gastroenterol 2012; 18(22): 2844-2849
- URL: https://www.wjgnet.com/1007-9327/full/v18/i22/2844.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i22.2844